Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-054517

Director sold 27,669 shares at an average $29.50 ($816,352)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
GADICKE ANSBERT Director 2021-08-31 Sale −177 $29.43 $5,209 259,975 D: show line 1 in the form
GADICKE ANSBERT Director 2021-08-31 Sale −1,285 $29.43 $37,818 7,759,840 I: show line 2 in the form
GADICKE ANSBERT Director 2021-08-31 Sale −215 $30.14 $6,480 259,760 D: show line 3 in the form
GADICKE ANSBERT Director 2021-08-31 Sale −1,553 $30.14 $46,807 7,758,287 I: show line 4 in the form
GADICKE ANSBERT Director 2021-09-01 Sale −790 $29.47 $23,281 258,970 D: show line 5 in the form
GADICKE ANSBERT Director 2021-09-01 Sale −5,714 $29.47 $168,392 7,752,573 I: show line 6 in the form
GADICKE ANSBERT Director 2021-09-02 Sale −2,178 $29.46 $64,164 256,792 D: show line 7 in the form
GADICKE ANSBERT Director 2021-09-02 Sale −15,757 $29.46 $464,201 7,736,816 I: show line 8 in the form
Open-market sales · 27,669 sh · avg $29.50 · $816,352
Loading xslF345X03/doc4.xml…